Dr Reddy's Laboratories gained a percent to Rs 3,173.50 at on BSE after the company announced that it has expanded its strategic collaboration with Amgen in India.
The announcement was made during market hours today, 16 September 2016.
Meanwhile, the S&P BSE Sensex was up 170.30 points or 0.6 percent at 28,582.25.
On BSE, so far 12,741 shares were traded in the counter as against average daily volume of 39,288 shares in the past one quarter. The stock hit a high of Rs 3,177.50 and a low of Rs 3,155 so far during the day. The stock had hit a record high of Rs 4,382.95 on 20 October 2015.
The stock had hit a 52-week low of Rs 2,750 on 21 January 2016. The stock had outperformed the market over the past one month till 15 September 2016, gaining 4.55 percent compared with 0.93 percent rise in the Sensex. The scrip had, however, underperformed the market in past one quarter, gaining 1.83 percent as against Sensex's 6.31 percent rise.
The large-cap company has equity capital of Rs 85.39 crore. Face value per share is Rs 5.
Looking for investment in Share Market, CapitalStars Financial Research Private Limited provides you best investments Tips in Share Market.It daily provides intraday and Future calls with profit assurity. You can plan your Future investments with us, Join and take our services and get benefits.
0 comments:
Post a Comment